Dividend stocks have vastly outperformed publicly traded companies that don't offer a payout over the last 50 years. Form 13F filings for the first quarter show that billionaire investors couldn't sto
A difficult period for Pfizer might be coming to an end, as serious setbacks and tough Y/Y comps are in the rearview mirror. The first quarter performance of the commercial business exceeded Street ex
Pfizer (PFE) closed at $27.66 in the latest trading session, marking a -1.32% move from the prior day.
Almost two-and-a-half years after Russia launched its full-scale invasion of Ukraine, the overwhelming majority of businesses in the country are operational, according to the research from the America
Pfizer said on Wednesday its experimental gene therapy for a type of muscle-wasting disorder did not meet the main goal of a late-stage trial.
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that CIFFREO, a Phase 3 global, multicenter, randomized, double-blind, placebo-controlled study evaluating the investigational mini-d

3 Hidden-Gem Value Stocks to Buy and Never Let Go

03:20pm, Wednesday, 12'th Jun 2024
In the volatile stock market, investing in undervalued stocks is generally a good way to go. There are plenty of hidden-gem value stocks out there, though by nature, something that's hidden needs to b

Pfizer: An Oversold Pharma Stock in Recovery

09:01am, Wednesday, 12'th Jun 2024
Some say the art of investing is the ability of catching falling knives. Pfizer Inc. (PFE, Financial) shares have sold off in 2023 and represent an attractive opportunity after having likely bottomed
Maintaining stability and security in investment portfolios is vital in an adverse macroeconomic environment. For instance, the current higher-for-longer interest rate environment coupled with other v
On Friday, the U.S. Federal Drug Administration (FDA) okayed the launch of updated vaccines as part of the 2024-2025 campaign against new Covid strains.  Drug manufacturers have been waiting on appro
Billionaires don't necessarily need passive income, but they like to buy dividend stocks for the outsized returns they can provide. After falling a long way from its previous peak, Pfizer stock offers
The S&P 500 has hit more than one record high this year, and technology stocks have led the gains. It's a great idea to get in on stocks that have remained in the doldrums but could have a bright futu
Pfizer Inc. (NYSE:PFE ) Goldman Sachs 45th Annual Global Healthcare Conference June 10, 2024 11:20 AM ET Company Participants Albert Bourla - Chairman and CEO Conference Call Participants Chris Shibut
Zacks.com users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Gilead Sciences is a safe, reliable dividend stock. Organon pays a high dividend yield and has been a big winner for investors this year.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE